Neuroscience researchers have identified a new molecular pathway underlying Parkinson's disease. The pathway involves polyamines, which were discovered to be responsible for increased build-up of other toxic proteins in neurons. The research also suggests polyamine lowering drugs could have a protective effect from Parkinson's disease.
